Physician profile
David J Evans
NPI 1164457446
$1,795.69
in general payments reported to CMS, 2019-2025
18 companies · $18.29 in 2025
The $18.29 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $257 · 2021: $483 · 2022: $369 · 2023: $124 · 2024: $72.39 · 2025: $18.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $849.33 | 2019-2022 | |
| Pfizer INC. | $197.99 | 2019-2023 | |
| Minerva Surgical, INC | $127.76 | 2019 | |
| Myovant Sciences INC. | $112.72 | 2021-2022 | |
| Evofem Biosciences, INC. | $80.48 | 2021-2024 | Phexxi |
| Mayne Pharma Commercial LLC | $73.82 | 2022-2023 | |
| Exeltis, USA INC. | $67.76 | 2021-2024 | Slynd |
| Lupin INC. | $50.99 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $37.52 | 2019-2020 | |
| Heron Therapeutics, INC. | $36.47 | 2023 | Zynrelef |
| Therapeuticsmd, INC. | $28.81 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $22.96 | 2024 | Myfembree |
| Medicem INC. | $21.50 | 2020 | |
| Hologic Sales and Service, LLC | $19.07 | 2020 | |
| Avion Pharmaceuticals | $18.44 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $18.29 | 2025 | Veozah |
| Currax Pharmaceuticals LLC | $16.05 | 2022 | |
| Mission Pharmacal Company | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.